“There is tremendous scope for extending cancer research in India”

Prof Ashok Venkitaraman is the Ursula Zoellner Professor of Cancer Research at the University of Cambridge, and the director of Medical Research Council (MRC) Cancer Unit at the Hutchison/MRC Research Center.


Prof Ashok Venkitaraman

He is a collaborative science chair at inStem and NCBS, Bangalore, and also coordinates at the Center for Chemical Biology and Therapeutics (CCBT).

In his exclusive interview with BioSpectrum, Prof Venkitaraman shared some of his research work and collaborations at Cambridge University. He feels that there is tremendous scope for extending cancer research in the academic and industrial sectors in India.

He believes that aspects of such efforts in the UK is a great place for oncology research based start-ups to translate laboratory discoveries to clinical application with the aim of delivering important new medical products.

He says that the best people in research, whether in academia or industry inevitably flock to the best places where they can carry out their research well, which in turn means that it will be important to build excellent institutions to attract such talents.

Q: What are the opportunities available for Indian oncology research start-ups to set foot in the UK?

Previous 1 3 4 5 Next
1 Comment Comment 1 - 1 of 1

disha 4 June 2015 at 07:54 PM

Is cancer biotechnology has scope for girls? In india we can get job for cancer biotechnology


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email